Shionogi & Co., Ltd. announced that it will implement the following corporate reorganization and personnel re-assignment as of April 1, 2013. The company will establish the Global SCM Division to manage Shionogi's entire supply chain including supply for all overseas businesses by expanding the function of the existing supply chain management department encompass all related global activities. In accordance with this objective, two new departments will be created under the auspices of the new global SCM division- the SCM planning department, to manage procurement, manufacturing and inventory control for each product, integrating global SCM activities from suppliers through to customers, and the production strategy department, responsible for the development of global strategic manufacturing plans and supply strategies for all Shionogi products for the entire Shionogi group. The company will create a new CMC development department, independent from the manufacturing & technology division. In accordance with this reorganization, the company will change the Japanese name of the CMC development laboratories from CMC GijutsuKenkyu-Sho to CMC Kaihatsu Kenkyu-Sho. Within the creation of independent CMC development department, the manufacturing & technology division will undergo certain organizational changes and be renamed the manufacturing division. The production strategy and planning department, responsible for functions related to CMC planning and production strategies, which was previously part of manufacturing & technology division will now move into CMC development laboratories and the global SCM division, and its name will be changed to production planning department and it will focus on manufacturing planning for key factories, including the Settsu plant and the kanegasaki plant, it will also manage manufacturing subsidiaries. A production department will be newly established under the manufacturing division to strengthen the production technologies of Shionogi's plants. The information resource management department will be dissolved and its strategic planning responsibilities will be absorbed into the corporate planning department allowing it plans to be developed in an integrated and responsive manner with Shionogi's overall corporate and business strategies.

The company also announced that Takeshi Shiota presently General Manager, Medical research laboratories has been reassigned as General Manager, innovative drug discovery research laboratories; Takuko Sawada presently executive officer, executive General Manager, global development office has been reassigned as senior executive officer, executive General Manager, global development office, pharmaceutical development division; Kazuhiro Htanaka presently general manager, clinical research department has been reassigned as deputy executive general manager, pharmaceutical development division; Takashi Fukunaga presently deputy general manager, clinical research department has been reassigned to general manager, clinical research department; Kiyoshi Nagata presently corporate officer, executive general manager, diagnostics division has been reassigned as corporate officer, executive general manager, CMC development laboratories; Miyuki Hiura presently deputy general manager, analytical development center has been reassigned as general manager, analytical development center; Takuo Fukuda presently executive officer, executive general manager, manufacturing & technology division has been reassigned as executive officer, executive general manager, manufacturing division; Yoshihiro Furuya presently general manager, analytical development center has been reassigned to general manager, Settsu plant; Toshio Kawakita presently plant QA manager, kanegasaki plant, QA unit has been reassigned as general manager, production planning department; Yasuyuki Kawanishi presently general manager, CMC development laboratories has been reassigned as general manager, production technology department; Takayuki Yoshioka corporate officer, executive general manager, pharmaceutical development division has been reassigned as corporate officer, executive general manager, quality, safety and regulatory affairs management division; Masahiro Ariyoshi presently deputy general manager, corporate quality assurance department has been reassigned as general manager, general marketing compliance officer; Hirosato Kondo presently corporate officer, executive general manager, quality, safety and regulatory affairs management division has been reassigned as corporate officer, executive general manager, global SCM division; Koukichi Kubota presently general manager, production strategy & planning department has been reassigned to general manager, production strategy department; Junichi Hirai presently president and representative director, Shionogi analysis center co., ltd has been reassigned as general manager, production strategy department; Akira Kato presently deputy general manager business development department has been reassigned to general manager, business development department; Tokio Iguchi presently general manager, human resources department has been reassigned to general manager, general administration & subsidiaries management department; Ryuichi Kiyama general manager, business development department has been reassigned to general manager, diagnostics division; Ikuo Kato general manager, drug developmental research laboratories, president and representative director, Shionogi techno advance research co., ltd. has been reassigned as general manager, drug developmental research laboratories, chairman of the board and representative director, Shionogi techno advance research co., ltd.; Jun Ishizaki presently general manager, innovative drug discovery research laboratories has been reassigned as president and representative director, Shionogi techno advance research co., ltd.; Yoshiyuki Takeuchi presently deputy general manager, chemical development center has been reassigned as president and representative director, Shionogi analysis center co., ltd.